Kelly W. Benton, VP and Chief Accounting Officer of Saia Inc, filed a Form 4 on November 4, 2026, disclosing a share withholding transaction on November 2, 2026, related to the vesting of restricted shares originally awarded in November 2022.
An amended beneficial ownership statement covering a transaction dated October 28, 2026 was filed on November 4, 2026, by Soumen Das, MiteshKumar Patel, SPACCatalyst LLC, and SPACCircle Sponsor LLC, each identified as reporting persons with respect to SPACCircle Acquisition Corp. (NASDAQ:SCQCU).
A Statement of Changes in Beneficial Ownership was filed on November 4, 2026, disclosing that SPACCircle Sponsor LLC surrendered 750,000 Class B ordinary shares of SPACCircle Acquisition Corp. to the issuer for no consideration, following the underwriters' forfeiture of the over-allotment option in connection …
Director Todd C. Fowler filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing his initial beneficial ownership position in Saia Inc following an event date of October 29, 2026.
Director Fred Hassan filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 156,658 restricted stock units in Recursion Pharmaceuticals, Inc. on November 2, 2026.
Director Blake Borgeson of Recursion Pharmaceuticals, Inc. filed a Form 4 on November 4, 2026, disclosing the sale of 40,000 shares of Class A Common Stock on November 3, 2026, under a pre-established Rule 10b5-1 trading plan.
Fred Hassan filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing his status as a newly appointed director of Recursion Pharmaceuticals, Inc. as of October 31, 2026.
Lorie Ann Boyd, Chief People Officer of Kodiak AI, Inc., filed an initial statement of beneficial ownership (Form 3) on November 4, 2026, with an event date of November 2, 2026.
An amended initial statement of beneficial ownership (Form 3/A) was filed on November 4, 2026, by Soumen Das, Miteshkumar Patel, SPACCircle Sponsor LLC, and SPACCatalyst LLC, each reporting their relationship to SPACCircle Acquisition Corp. as of the event date of October 26, 2026.
AngioDynamics President and CEO Eric Honroth filed a Form 4 on November 4, 2026, disclosing the acquisition of restricted stock units and performance rights on November 2, 2026, resulting in beneficial ownership of 101,193 shares of common stock.